Literature DB >> 3818954

Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent.

M E Smith, D M Reid, C E Jones, J V Jordan, C A Kautz, N R Shulman.   

Abstract

The antibody domain controlling reactions between platelet membranes and drug-dependent (dd) antibodies from patients with thrombocytopenia induced by cinchona alkaloids was studied using F(ab')2, Fab, and Fc fragments made from purified dd-IgG. By direct binding radioimmunoassay (RIA) measurements, 20,000 to 50,000 antibody molecules bound per platelet equivalent of purified platelet membranes at apparent saturation with three different antibodies. F(ab')2 and Fab fragments bound to platelet membranes drug dependently but Fc fragments did not. The ability of dd-IgG fragments to compete with intact IgG was quantitatively measured by RIA and by complement fixation. F(ab')2 and Fab competed with intact IgG at an 8:1 and greater than 50:1 molar ratio, respectively, in RIA, and at a 1.6-3:1 and 44-75:1 ratio, respectively, by complement fixation assays. Fc did not compete with IgG in either assay. We conclude that the Fab domain supports attachment of dd antibody to the platelet surface.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818954      PMCID: PMC424235          DOI: 10.1172/JCI112901

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A MECHANISM OF CELL DESTRUCTION IN INDIVIDUALS SENSITIZED TO FOREIGN ANTIGENS AND ITS IMPLICATIONS IN AUTO-IMMUNITY. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

Authors:  N R SHULMAN
Journal:  Ann Intern Med       Date:  1964-03       Impact factor: 25.391

2.  Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307

3.  Antibody affinity. 3. The role of multivalance.

Authors:  C L Hornick; F Karuch
Journal:  Immunochemistry       Date:  1972-03

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Isolation and characterization of plasma membranes from human blood platelets.

Authors:  A J Barber; G A Jamieson
Journal:  J Biol Chem       Date:  1970-12-10       Impact factor: 5.157

6.  Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia.

Authors:  D J Christie; P C Mullen; R H Aster
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

7.  Evaluation by quantitative acid elution and radioimmunoassay of multiple classes of immunoglobulins and serum albumin associated with platelets in idiopathic thrombocytopenic purpura.

Authors:  A J Hotchkiss; C A Leissinger; M E Smith; J V Jordan; C A Kautz; N R Shulman
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

8.  Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

9.  [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs.

Authors:  R K Assoian; N E Thomas; E T Kaiser; H S Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Fc receptors of a human promyelocytic leukemic cell line: evidence for two types of receptors defined by binding of the staphylococcal protein A-IgG1 complex.

Authors:  G R Crabtree
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

View more
  7 in total

1.  Anion channel blockers cause apparent inhibition of exocytosis by reacting with agonist or secretory product, not with cell.

Authors:  J G Vostal; D M Reid; C E Jones; N R Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa.

Authors:  Daniel W Bougie; Julie Peterson; Mark Rasmussen; Richard H Aster
Journal:  Blood       Date:  2015-09-09       Impact factor: 22.113

3.  Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies.

Authors:  Daniel W Bougie; Peter R Wilker; Richard H Aster
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

4.  Structural basis for quinine-dependent antibody binding to platelet integrin αIIbβ3.

Authors:  Jianghai Zhu; Jieqing Zhu; Daniel W Bougie; Richard H Aster; Timothy A Springer
Journal:  Blood       Date:  2015-08-17       Impact factor: 22.113

Review 5.  Drug-induced thrombocytopenia.

Authors:  Gian Paolo Visentin; Chao Yan Liu
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

Review 6.  Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.

Authors:  R H Aster; B R Curtis; J G McFarland; D W Bougie
Journal:  J Thromb Haemost       Date:  2009-04-02       Impact factor: 5.824

7.  A Shot in the Arm for Vaccination Intention: The Media and the Health Belief Model in Three Chinese Societies.

Authors:  Ruoheng Liu; Yi-Hui Christine Huang; Jie Sun; Jennifer Lau; Qinxian Cai
Journal:  Int J Environ Res Public Health       Date:  2022-03-20       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.